Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurolock for Prevention of Catheter Infections in Cancer Patients
NCT02255318Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Catheter-related infection (CRI) comparing Taurolock with Placebo (2 arms). Primary endpoint: Incidence rate of infections related to chamber implantable catheters at 3 months. Status: unknown.
02
Drugs
taurolidine
03
Conditions
Catheter-related infection (CRI)
Beyond the preview
Go deeper on NCT02255318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255318.